These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4287002)

  • 1. [Antiviral activity of IDU against herpes simplex virus].
    Kobayashi S; Nakamura T; Asayama T
    Nihon Ganka Kiyo; 1965 Jan; 16(1):66-9. PubMed ID: 4287002
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of idoxuridine and persistence of herpes simplex virus in brains of patients being treated for encephalitis.
    Lauter CB; Bailey EJ; Lerner AM
    Proc Soc Exp Biol Med; 1975 Oct; 150(1):23-7. PubMed ID: 171683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental infection with herpes simplex virus type 2 in newborn rats: Effects of treatment with iododeoxyuridine and cytosine arabinoside.
    Percy DH; Hatch LA
    J Infect Dis; 1975 Sep; 132(3):256-61. PubMed ID: 169311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated herpes-simplex-virus infections.
    Nahmias AJ
    N Engl J Med; 1970 Mar; 282(12):684-5. PubMed ID: 4190592
    [No Abstract]   [Full Text] [Related]  

  • 5. [Idoxuridine treatment of herpes virus infections].
    Wildenhoff KE; Esmann V
    Ugeskr Laeger; 1979 May; 141(19):1288-9. PubMed ID: 222029
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influence of various factors on the proliferation of herpes simplex virus. II. With regard to the problem of tolerance of the herpes simplex virus for IDU].
    Oshima K
    Nippon Ganka Gakkai Zasshi; 1967 Aug; 71(8):1211-6. PubMed ID: 4295686
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acquired idoxuridine resistance of herpes simplex virus. Clinical data (author's transl)].
    Colin J; Chastel C
    Sem Hop; 1978 Oct 18-25; 54(33-36):1071-2. PubMed ID: 220719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter: Therapy of herpes simplex virus encephalitis.
    N Engl J Med; 1975 Jun; 292(25):1354-5. PubMed ID: 165413
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of herpes simplex virus isolated from patients with recurrent herpes keratitis exhibiting "treatment-resistance" to 5-iodo-2'-deoxyuridine.
    Hirano A; Yumura K; Kurimura T; Katsumoto T; Moriyama H; Manabe R
    Acta Virol; 1979 May; 23(3):226-30. PubMed ID: 41435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine.
    Kern ER; Overall JC; Glasgow LA
    J Infect Dis; 1973 Sep; 128(3):290-9. PubMed ID: 4353930
    [No Abstract]   [Full Text] [Related]  

  • 11. [Aspects of antiviral therapy in herpes infections].
    Gologan R
    Stud Cercet Virusol; 1972; 23(1):47-68. PubMed ID: 4361689
    [No Abstract]   [Full Text] [Related]  

  • 12. Attempt at inhibiting B virus (herpes virus simiae) growth in rabbits by 5-iodo-2'-deoxyuridine.
    Benda R
    Acta Virol; 1965 Nov; 9(6):556. PubMed ID: 4379443
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of 5-iodo-2'-deoxyuridine (IUDR) in Orabase and plastibase for treatment of oral herpes simplex.
    Najjar TA; Sleeper HR; Calabresi P
    J Oral Med; 1969 Apr; 24(2):53-7. PubMed ID: 4308869
    [No Abstract]   [Full Text] [Related]  

  • 14. Herpes simplex encephalitis. A report of three further cases.
    Lynch PG; Longson MR
    Pathol Eur; 1973; 8(2):149-61. PubMed ID: 4359249
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative measures of sensitivity of isolates and concentrations of idoxuridine in body fluids of patients with Herpesvirus encephalitis.
    Lerner AM; Bailey EJ
    J Lab Clin Med; 1971 Dec; 78(6):983-4. PubMed ID: 4331977
    [No Abstract]   [Full Text] [Related]  

  • 16. [Herpes simplex encephalitis. Acute necrotizing encephalitis and benign herpes simplex encephalitis].
    Buhl M
    Ugeskr Laeger; 1974 Apr; 136(15):815-21. PubMed ID: 4363988
    [No Abstract]   [Full Text] [Related]  

  • 17. Intranasal challenge of mice with herpes simplex virus: an experimental model for evaluation of the efficacy of antiviral drugs.
    De Clercq E; Luczak M
    J Infect Dis; 1976 Jun; 133 Suppl():A226-36. PubMed ID: 180205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy for human herpesvirus infections. A perspective.
    Whitley RJ
    Ala J Med Sci; 1985 Apr; 22(2):193-207. PubMed ID: 2988359
    [No Abstract]   [Full Text] [Related]  

  • 19. [(E)-5-(2-bromovinyl)-2'-desoxyuridine--a new nucleoside analog with selective inhibitory action against herpesviruses. Studies in cell culture and animal experiments].
    Reefschläger J; Wutzler P; Thiel KD; Töpke H; Bärwolff D; Langen P
    Pharmazie; 1987 Jun; 42(6):407-11. PubMed ID: 2823299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nucleosides in virus and cancer chemotherapy.
    Prusoff WH; Chen MS; Fischer PH; Lin TS; Shiau GT; Schinazi RF
    Adv Ophthalmol; 1979; 38():3-16. PubMed ID: 230724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.